Approximately half of the world's population suffer from active headaches 1 , which, despite being regarded as the third most common cause of disability 2 , still remains underdiagnosed and undertreated. Consequently, there is a need for studies providing insight into the pathophysiology of migraine and tension-type headache (TTH), as the most common causes of headache.
Migraine and TTH are often accompanied by psychiatric disorders, the most widely known and extensively studied of which are those involving anxiety and depression 3 . Little is known, however, about the somatic symptoms and health anxiety associated with headaches. The presence of comorbid psychiatric disorders is associated with the progression to chronic migraine 4 or disability 5 . The early recognition of any comorbid psychiatric disorders and the elucidation of factors affecting these comorbid conditions are important for disease prognosis.
Somatosensory amplification (SSA) refers to the experiencing of normal and harmless sensations as intense and disturbing, and was first described by Barsky 6 . Only one study to date has demonstrated that migraine patients have a tendency to notice bodily sensations to a greater degree 5 , while there have been no studies replicating this finding and comparing it with TTH.
Health anxiety refers to the belief that one has a serious illness, based on a misinterpretation of bodily sensations and a high level of anxiety about health status 7 . There is evidence suggesting a close relationship between increased somatic symptom load and health anxiety 8 that has raised questions of whether patients with headaches reporting excessive somatic symptoms 9,10 also have increased health anxiety. To the best of our knowledge, there has been no study to date evaluating SSA and health anxiety in patients with migraine and TTH. The present study aimed to determine whether differences exist between patients with migraine, TTH and healthy controls in terms of SSA and health anxiety; to identify any relationship with symptoms of depression and anxiety if a difference between the groups is identified; and to evaluate whether a relationship exists between the characteristic features of headache, SSA and health anxiety.
METHODS

Study sample
The study included 54 patients with migraine and 50 patients with TTH who were admitted to the neurology outpatient clinic of the Research and Application Hospital of the Yozgat Bozok University School of Medicine between May 2018 and February 2019. All patients were evaluated by a neurologist and diagnosed with either migraine or TTH, based on the criteria of the International Classification of Headache Disorders, third edition beta version 11 . The study was approved by the ethics committee of the Bozok University School of Medicine, and all patients participating in the study signed an informed consent form. The inclusion criteria were an age between 18 and 60 years, a diagnosis of migraine or TTH, and willingness to participate in the study. The exclusion criteria were the presence of chronic migraine or TTH, a comorbid neurologic disease, mental retardation, psychiatric comorbidities, chronic disease or malignancy and illiteracy. The control group comprised 53 healthy volunteers with no known neurological or psychiatric illnesses.
Age, sex, educational status and occupation of the participating patients were recorded, and the frequency of headaches was recorded as the number of episodes per month and disease duration in years. A visual analogue scale (VAS) was used to determine the severity of headaches, with a VAS score of 1-3 points indicating mild pain, a score of 4-6 points indicating moderate pain, a score of 7-8 points indicating severe pain, and a score of 9-10 points indicating extremely severe pain 12 .
Scales used in the study
Somatosensory Amplification Scale (SSAS): This 10-item scale was developed by Barsky et al. 13 to evaluate the tendency to experience normal bodily sensations as disturbing. The items are scored from 1-5 points. Most of the items are related to a range of disturbing bodily sensations that are not symptoms of disease. The total score on this scale indicates the level of exaggeration of bodily sensations. The validity and reliability of the Turkish version of the scale have been demonstrated 14 .
Health Anxiety Inventory: This is an 18-item self-reported scale developed by Salkovskis et al. 15 The items are scored from 0-3, with a higher total score on the scale indicating a high level of health anxiety. A validity and reliability study has been conducted 16 .
Beck Depression Inventory (BDI): This is a 21-item self-reported questionnaire for evaluating the symptoms and severity of depression. Each item is scored from 0-3. The inventory was developed by Beck et al. 17 and the validity and reliability of the Turkish version have been evaluated 18 .
Beck Anxiety Inventory (BAI): This is a 21-item self-reported questionnaire evaluating the symptoms and severity of anxiety 19 . The scale evaluates the physical, emotional and cognitive aspects of anxiety, and has been demonstrated to be a valid and reliable tool for use in the Turkish population 20 .
Statistical analyses
Statistical analyses were performed using the Statistical Package for the Social Sciences, version 20. The categorical variables are presented as percentage and counts. The continuous variables are shown as the mean and standard deviation. The variables were investigated using visual (histograms, probability plots) and analytical methods (Kolmogorov-Smirnov test) to determine whether or not they were normally distributed. The independent sample t-test was used for comparison between the continuous variables and the chi-square test for the categorical variables. One-way ANOVA was used to compare the SSAS, health anxiety, BDI and BAI scores between the three groups, since parametric test assumptions were met. The Levene test was used to assess the homogeneity of the variances. When an overall significance was observed, pairwise post hoc tests were performed using Tukey's or Tamhane's T2 tests according to homogeneity of variance. The relationships between the variables were evaluated using Pearson's correlation analysis. The level of statistical significance was set at p < 0.05.
RESULTS
The sociodemographic characteristics of the patients with migraine and TTH, as well as the control participants, are presented in Table 1 . There was no significant difference between the groups in terms of age or sex (p > 0.05). The differences between the patients with migraine and TTH in terms of pain characteristics are presented in Table 2 .
The comparison of the SSAS, health anxiety, BAI and BDI scores of the groups is presented in Table 3 . Statistically significant differences were found between all scores of all groups. A post hoc analysis showed significantly higher SSAS scores in the migraine group (p = 0.001). While no significant difference was identified between the patients with TTH and the healthy controls (p = 0.111), the SSAS scores did not differ significantly between the patients with migraine and those with TTH (p > 0.05). A comparison of the health anxiety scores of the different groups identified significantly higher scores in both the migraine and TTH groups when compared with the healthy controls (migraine group p = 0.008, TTH group p < 0.001). The comparison of BAI and BDI scores also showed significantly higher scores in the migraine and TTH groups than in the healthy control group (p < 0.001).
A correlation analysis of the SSAS, health anxiety, BAI and BDI scores and the characteristics of headaches in the migraine patients (Table 4 ) showed a significant positive correlation between the VAS scores and the SSAS and BDI scores (r = 0.278 p < 0.05, r = 0.286 p < 0.05, respectively). There was also a significant positive correlation between the frequency of pain and the BAI score (r = 0.289, p < 0.05). No significant correlation was identified between the variables and the duration of pain. A significant positive correlation was noted between the SSAS score and the BAI and BDI scores (r = 0.491 p < 0.01, r = 0.303 p < 0.05, respectively). The health anxiety score was found to be correlated with the BAI and BDI scores (r = 0.330 p < 0.05, r = 0.555 p < 0.01, respectively). A correlation analysis using the same parameters in patients with TTH showed no significant correlation between headache characteristics and the variables. Similar to that in the migraine group, a significant positive correlation was found between the SSAS score and the BAI and BDI scores of patients with TTH (r = 0.655 p < 0.01, r = 0.518 p < 0.01, respectively). There was also a significant correlation between the health anxiety score and the BAI and BDI scores (r = 0.531 p < 0.01, r = 0.458 p < 0.01, respectively).
DISCUSSION
The results of the present study revealed that migraine patients had a higher tendency to be aware of bodily sensations than healthy controls, and that patients with TTH were similar to the healthy controls in terms of somatosensory amplification. This finding is consistent with the study by Yavuz et al., who showed similar findings in patients with migraine 5 , although their study included all patients with migraine, and made no differentiation between episodic and chronic migraine. The present study included only patients with episodic migraine to ensure a more homogeneous study group, given that there are important pathophysiological and clinical differences between episodic and chronic migraine 20 . It has been reported that migraine is often accompanied by such functional somatic syndromes as fibromyalgia, irritable bowel syndrome, chronic fatigue syndrome and back pain 9, 22 . The authors attribute this to the common pathophysiological mechanism of central sensitization, and the increased SSA among migraine patients in the present study can be regarded as a reflection of this. Pain modulation in the central nervous system is altered, resulting in increased neuronal excitability and/or decreased inhibitor mechanisms, leading to sensitization. Although it is not known how this system is activated and maintained, genetic predisposition is said to be involved in the more susceptible individuals 23 .
There have been previous studies reporting on the role of repetitive painful stimuli in central sensitization 24 , although the present study found no relationship between SSA and pain frequency. Furthermore, SSAS scores have been found to be lower in patients with TTH, in whom the frequency of pain is higher than in patients with migraine. The SSAS scores were found to be weakly correlated with the severity of pain in the present study. Maizel et al. have also found a relationship between headache severity and somatic symptoms 10 . Another study, conducted on patients with fibromyalgia and chronic fatigue syndrome, found a correlation between somatosensory amplification and pain severity 25 . These individuals may be susceptible to somatic symptoms and, therefore, perceive more intense pain.
Based on the assumption that SSA has three components (1 -increased attention to bodily sensations, 2focus on some of the weaker and infrequent bodily sensations, and 3 -cognitive and emotional reactions to bodily sensations) 6 , migraine patients may focus more on their body sensations and pay increased attention in this regard. According to a theory proposed by Köteles et al. 26 , SSA does not refer solely to the amplification of sensations, but it also reflects increased sensitivity to a threat to bodily integrity. That is, these individuals are hypersensitive to any external threat, which may be considered a type of defense mechanism that allows an organism to survive. This hypersensitivity is an adaptive response in the early periods of life, but loses its adaptive feature over time. 26 Exposure to trauma or stressful experiences are said to play a role in the development of threat hypersensitivity 25 and, indeed, studies demonstrating greater traumatic experiences in patients with migraine and TTH than in healthy controls provide evidence of this 27, 28 .
One of the most important findings of the study is that health anxiety is higher in both types of headaches than in the healthy controls. To the best of our knowledge, there has been no other study in the literature to date investigating health anxiety in patients with migraine and TTH. Although migraine patients have a higher perception of bodily sensations than patients with TTH, the presence of health anxiety in the two patient groups is an interesting finding. There are also other factors mediating the development of health anxiety, one of which is catastrophic thought, as proposed in the model by Seto et al. 29 . According to this notion, perceived bodily sensations exacerbate and transform into disturbing symptoms with catastrophizing and excessive interpretation. The higher health anxiety scores in patients with TTH without significant SSA may be linked to the tendency of these patients to catastrophize bodily sensations, although the present study did not make use of any scale to evaluate catastrophic interpretations. Further studies involving such evaluations may provide additional data on this subject.
Another finding of the present study was the higher anxiety and depression scores in patients with migraine and TTH than in the healthy controls 30, 31 , which is consistent with the findings of previous studies. The presence of common pathophysiological mechanisms associated with migraine and anxiety and depressive disorders 32 , and therapies involving antidepressants 33 and psychotherapies 34 proving useful in both conditions, may explain why migraines are often accompanied by psychopathological conditions.
The presence of a strong relationship between SSA and health anxiety, and depression and anxiety, in both groups was one of the most important findings of the present study. Different from the present study, Yavuz et al. 5 identified a relationship between SSA and anxiety in migraine patients, whereas no relationship was reported between depression and SSA. To the best of our knowledge, the present study is the first to report a relationship between health anxiety, depression and anxiety in headaches.
A relationship was found between BAI scores and the frequency of episodes, and between BDI scores and VAS scores in migraine patients. Studies evaluating the relationship between the frequency and severity of episodes and depression and anxiety have yielded controversial results. In a study of migraine patients, it was found that the coexistence of anxiety and depression was related to the frequency of headache episodes, while anxiety was found to be related to the VAS score 35 . Another study comparing patients with migraine and non-migraine headaches reported a relationship between attack frequency, and anxiety and depression 36 . In another study of migraine patients, severity of headache was found to be correlated with depression and emotional stress, whereas attack frequency was not found to be correlated with the presence of any psychopathology 37 . The differences between the results may be attributed to the different sample sizes and methodological differences.
In the TTH group, no relationship was identified between the frequency and severity of episodes and the BDI and BAI scores. There have been studies reporting a relationship between the level of anxiety and the frequency of episodes in patients with chronic TTH 38 , although these studies have mostly involved patients with chronic TTH. The authors, therefore, consider that future studies evaluating the relationship between the frequency and severity of episodes and various psychopathologies in patients with episodic TTH could fill the gaps in this field.
The present study has some limitations, one of which is its cross-sectional design, as not being designed as a longitudinal study complicates the establishment of a causal relationship. Another limitation is that the scales used in the study are based on the self-reports of the patients. Although self-report forms can be considerably useful in the presence of time constraints, they may fail to determine the general condition of an individual as they reflect on their condition at the time of response. Another characteristic that could be regarded as a limitation is the greater number of females than males in the study. In fact, this reflects the real numbers, as it is well known that headaches are more common in females. Nonetheless, large-scale studies with a larger number of male patients would aid in the generalization of the results of the study.
In conclusion, although the present study identified a high level of health anxiety among patients with both migraine and TTH, the higher level of SSA only in patients with migraine is a finding supporting the central sensitization theory, and the assumption that these two types of headaches have different pathophysiological mechanisms. Health anxiety and SSA were found to be strongly related to anxiety and depression. Addressing patients with migraine and TTH through a multidisciplinary approach, and assessing SSA and health anxiety, may provide a positive contribution to the diagnosis and treatment of these patients. Raising awareness of pain and providing patients with psychoeducation through the identification of catastrophizing thoughts may be useful, 29 and may perhaps prevent progression to chronic pain. There is a need for prospective studies involving larger samples. The authors believe that testing the use of the SSAS as a tool for the prediction of progression to chronic migraine in studies involving patients with chronic headache may make a significant contribution to the literature, although no such assessment was made in the present study.
